FDA Inspection 771020 — Clay, Dr Patrick

Clay, Dr Patrick — FEI 3009421004

The FDA completed an inspection of Clay, Dr Patrick on Mar 19, 2012 in Kansas City, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 19, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Kansas City, MO (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate